课题基金 / 基金详情

Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections

Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections
Plac8 在针对衣原体感染的自然免疫和疫苗免疫中的作用
批准号:
9114842
负责人:
Robert Conrad Brunham
金额:
$37.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2019-06-30

项目摘要

项目成果

Robert Conrad Brunham的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chlamydia trachomatis infections have a prevalence of 2-15% in adolescents/young adults in the USA and Western Europe in spite of public health efforts and effective antibiotic therapy. It is widely accepted that development of a Chlamydia vaccine is necessary reduce its prevalence. A critical component of vaccine development is identification of a surrogate biomarker for protective immunity to enable screening of candidate vaccines. Currently there are no practicable biomarkers for Chlamydia protective immunity. The Johnson laboratory has identified a second CD4 T cell-mediated mechanism singly-sufficient for clearing Chlamydia from the genital tract that is dependent on Plac8. The Brunham laboratory has demonstrated that vaccine-generated protective immunity against Chlamydia genital tract infections requires a multifunctional Th1 response. The two laboratories approaching protective immunity from different perspectives have converged on working model for protective immunity that has major potential implications for vaccine development. Supported by published and unpublished data they postulate that the foundation of a protective C. trachomatis vaccine will be generation of a multifunctional CD4Plac8 anti-Chlamydia response, and that multifunctional CD4Plac8 T cell responses will serve as practicable biomarkers for protective immunity and vaccine efficacy. To test that hypothesis and investigate the underlying immunobiology they propose the following specific aims: Specific aim #1- to investigate the role of the Plac8-dependent clearance mechanism in vaccine-generated protective immunity. This aim will utilize the Brunham laboratory's published protective murine PmpG vaccine, and existing knockout mice. Specific aim #2- to investigate the effector mechanism associated with Plac8-dependent immunity. This aim will utilize the Johnson lab's published Chlamydia-specific Plac8pos and Plac8neg CD4 T cell clones, and Plac8 knockout reproductive tract epithelial lines. Specific aim #3- to investigate the frequency and distribution of multifunctional CD4Plac8 T cells in mice and humans, in the absence and presence of Chlamydia infections. This is novel translational research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infections
  • 批准号:
    9303878
  • 项目类别:
  • 资助金额:
    $34.75万
  • 财政年份:
    2015
  • 负责人:
    Robert Conrad Brunham
  • 依托单位:
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infecti
Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infecti
Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics
  • 批准号:
    7532756
  • 项目类别:
  • 资助金额:
    $25.38万
  • 财政年份:
    2008
  • 负责人:
    Robert Conrad Brunham
  • 依托单位:
国内基金
海外基金
Plac8通过激活自噬促进牙胚矿化和发育成牙
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    蔡景蕾
  • 依托单位:
PLAC8下调XAF1增强NF-κB信号传导促进脑胶质瘤增殖的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    王岩
  • 依托单位:
PLAC8调控胎盘铁代谢及免疫微环境参与子痫前期发生的分子机制
  • 批准号:
    82371687
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    赵洪波
  • 依托单位:
超级增强子驱动PLAC8在PRL-3诱导结肠癌化疗耐药中的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    来伟
  • 依托单位: